Schuetz, Thomas
Dolejsi, Theresa
Beck, Eva
Fugger, Fabio
Bild, Alexander
Duin, Marie-Theres
Gavranovic-Novakovic, Jasmina
Hilbold, Erika
Hoffmann, Thomas
Zuber, Johannes
Bauer, Axel
Ruschitzka, Frank
Bär, Christian
Penninger, Josef Martin
Haubner, Bernhard Johannes
Funding for this research was provided by:
Österreichische Kardiologische Gesellschaft
Bundesministerium für Bildung und Forschung (01KL1903, 01KX2324)
Fondation Leducq (21CVD03)
T. Von Zastrow Foundation
Medizinische Universität Wien
Canada 150 Research Chairs Program (F18-01336)
Austrian Science Fund (I 4161-B)
Medizinische Universität Innsbruck (2017-01-014)
Medizinischer Forschungsfonds Tirol
Article History
Received: 8 January 2024
Accepted: 10 September 2024
First Online: 30 September 2024
Declaration
:
: FR has not received personal payments by pharmaceutical companies or device manufacturers in the last 3 years (remuneration for the time spent in activities, such as participation as steering committee member of clinical trials and member of the Pfizer Research Award selection committee in Switzerland, were made directly to the University of Zurich). The Department of Cardiology (University Hospital of Zurich/University of Zurich) reports research-, educational- and/or travel grants from Abbott, Abiomed, Alnylam, Amarin, Amgen, Astra Zeneca, At the Limits Ltd., Bayer, Biotronik, BMS, Boehringer Ingelheim, Boston Scientific, Bracco, CM Microport, Concept Medical, CTI, Daiichi Sankyo, Edwards Lifesciences, FomF GmbH, Hamilton Health Sciences, IHF, Innosuisse, IumiraDX, Kantar, LabPoint, MedAlliance, Medcon International, Medical Education Global Solutions, Medtronic, MicroPort, Monocle, Novartis, Novo Nordisk, OM Pharma, Pfizer, Quintiles Switzerland Sarl, RecorMedical, Roche Diagnostics, Roche Pharma, Sahajanand IN, Sanofi, Sarstedt AG, Servier, Terumo Deutschland, Trama Solutions, V-Wave, Vifor, ZOLL. These grants do not impact on Prof. Ruschitzka’s personal remuneration.